Will Chemometec A/S stock go up?

According to Danelfin AI, Chemometec A/S has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (46.15%) is -3.44% vs. the average probability (49.60%) of all European stocks.

Is it a good time to buy, sell, or hold Chemometec A/S stock right now?

Chemometec A/S has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (46.15%) is -3.44% vs. the average probability (49.60%) of all European stocks, based on our AI-powered analysis. You can find more details on whether Chemometec A/S stock is a good buy .

What is going on with Chemometec A/S stock in the last 3 months?

The Chemometec A/S stock performance in the last quarter has been +31.65%.

Does Chemometec A/S offer dividend payments?

Yes, Chemometec A/S stock dividend yield is 1.72%.

What is the current market capitalization of Chemometec A/S?

Chemometec A/S's market cap is DKK 6.3B, as of 2026-07-03 08:00.

Chemometec A/S (CHEMM.CO) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

CHEMM.CO AI-Powered Stock Analysis

AI Score Explanation

AI Score

Hold

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, Chemometec A/S today receives an AI Score of 4/10, which translates to a Hold rating. The stock has a 46% probability of outperforming the market in the next 3 months, which is 4% lower than the average probability of any stock (50%). Among the top positive contributors, Consolidated Net Income / Loss (top 30%) adds +0.65% to the probability, Diluted EPS (top 10%) adds +0.47%, and Chart Pattern (180d) adds +0.43%. On the negative side, the Industry (GICS) (Life Sciences Tools & Services) detracts -2.50%, the Chart Pattern (252d) detracts -0.85%, and Avg. Last Decile Drawdown (1Y) (bottom 10%) detracts -0.74%. Notable data points include Diluted EPS in the top 10% with a value of 5.40, indicating strong profitability, and Consolidated Net Income in the top 30% at 93.975 million, reinforcing solid earnings. However, Avg. Last Decile Drawdown (1Y) is in the bottom 10% with a value of -0.157, signaling elevated downside risk, and Recovery Upside is also in the bottom 10% at -0.259, suggesting the stock has not fully recovered from recent drawdowns. The net effect of all signals is negative (-3.72%), which aligns with the Hold rating, indicating a balanced risk-reward profile with no clear edge over the market.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Profitability+0.96%
Profitability and operating efficiency metrics
Growth+0.47%
Expected pace of revenue and earnings expansion
Earnings Quality+0.40%
Stability and reliability of reported earnings
Valuation+0.25%
How the stock is priced relative to its fundamentals

Momentum-2.26%
Direction and strength of recent price movements
Sentiment-2.09%
How analysts and the market view the stock
Volatility-1.03%
How much the stock price tends to fluctuate
Financial Strength-0.14%
Balance sheet strength and financial resilience

CHEMM.CO probability advantage of beating the market (3M):

-3.44%

AI Score

Hold

Chemometec A/S (CHEMM.CO) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -3.44% of beating the market (STOXX 600) in the next 3 months. This advantage is calculated as the difference between the average probability of any European stock (49.60%) and the probability of CHEMM.CO (46.15%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any European stock of beating the market (3M)49.60%
CHEMM.CO probability advantage of beating the market (3M)-3.44%
CHEMM.CO probability of beating the market (3M)46.15%

CHEMM.CO probability advantage of beating the market (3M): -3.44%

The AI-powered overall analysis of Chemometec A/S (CHEMM.CO) is based on the 33 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 24 months (alpha signals). These alpha signals explain the probability advantage of CHEMM.CO:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Life Sciences Tools & Services	N/A	-2.50%
Technical	Chart Pattern (252d)	figure_31	N/A	-0.85%
Technical	Avg. Last Decile Drawdown (1Y)	-0.16	N/A	-0.74%
Fundamental	Consolidated Net Income / Loss	93.98M		+0.65%
Technical	Distance from KAMA (100d)	0.13%		-0.56%
Technical	Technicals Impact (Long Tail)	-	N/A	-0.49%
Fundamental	Diluted EPS	5.4		+0.47%
Technical	Chart Pattern (180d)	figure_28	N/A	+0.43%
Technical	Chart Pattern (60d)	figure_158	N/A	-0.40%
Technical	Alpha YTD	-0.50%	N/A	+0.34%
Technical	Upgrade to unlock			-0.34%
Technical	Upgrade to unlock			-0.29%
Fundamental	Upgrade to unlock			+0.27%
Fundamental	Upgrade to unlock			+0.27%
Fundamental	Upgrade to unlock			+0.25%

Rest of Alpha Signals: +0.03%

CHEMM.CO probability advantage of beating the market (3M)Total:-3.44%
CHEMM.CO AI Score

Significant changes Vs previous day

CHEMM.CO Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:DKK 406.80
Horizon: 3 months
Stop Loss:DKKXXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:DKKXXXXXPro (XXXXX
Pro
) or AI Score < 4/10

CHEMM.CO Proven Hold Signal & Price Forecast

This is the price chart for CHEMM.CO from January 2, 2026 until today. The chart indicates, in yellow, the 111 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

CHEMM.CO Average Past Performance & Win Rate

Three months after its 1024 Hold signals since July 2026, CHEMM.CO had an average performance of xxxxxxx and a xxxxxx Win rate (positive performance).

1024 Past CHEMM.CO Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+87.06%
Average Alpha				+39.77%
Win Rate (% Positive Perf.)				77.23%
% Positive Alpha				100.00%

CHEMM.CO Frequently Asked Questions

Will Chemometec A/S stock go up?
According to Danelfin AI, Chemometec A/S has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (46.15%) is -3.44% vs. the average probability (49.60%) of all European stocks.
Is it a good time to buy, sell, or hold Chemometec A/S stock right now?
What is going on with Chemometec A/S stock in the last 3 months?
Does Chemometec A/S offer dividend payments?
What is the current market capitalization of Chemometec A/S?

Chemometec A/S Company Profile

Chemometec A/S (CHEMM.CO) is a leading Danish biotechnology company specializing in the development, manufacturing, and global sale of high-precision instruments and consumables for automated cell counting and analysis. Its innovative solutions are indispensable for critical quality control, process optimization, and advanced research applications within the pharmaceutical, biotechnology, and rapidly expanding cell therapy industries. By providing highly accurate, reliable, and reproducible data, Chemometec's technology plays a pivotal role in accelerating drug development pipelines, optimizing biomanufacturing processes, and advancing scientific discovery across various life science domains.

The company's flagship product line, NucleoCounter®, leverages advanced image cytometry technology to deliver automated, user-friendly, and highly reproducible cell analysis. These sophisticated instruments are meticulously engineered to meet the stringent regulatory requirements prevalent in the life sciences sector, making them essential tools for research and development laboratories, large-scale production facilities, and quality assurance departments worldwide. The comprehensive NucleoCounter® portfolio addresses a broad spectrum of applications, ranging from fundamental cell concentration and viability measurements to more complex analyses of cell health, apoptosis, and transfection efficiency, providing critical insights at every stage of the cell culture workflow.

Chemometec distinguishes itself through a relentless commitment to innovation, a robust intellectual property portfolio, and a steadfast focus on delivering superior accuracy, ease of use, and regulatory compliance. This dedication underpins its strong market position and reputation as a trusted partner for leading biopharmaceutical companies and research institutions globally. The increasing global demand for advanced cell-based therapies, biologics, and personalized medicine continues to fuel the need for precise, efficient, and standardized cell analysis, strategically positioning Chemometec for sustained growth and market expansion in these high-growth segments.

The company's strategic focus on technological leadership and customer-centric solutions drives significant long-term value for its shareholders. Chemometec's revenue mix is predominantly balanced between instrument sales and recurring consumable revenue, distributed through a combination of direct sales channels and a robust network of specialized distribution partners, serving a global customer base spanning key markets in North America, Europe, and Asia.

Sector:
Country:Denmark
Industry:
Address:Gydevang 43, ALLEROED
Employees:172
Website:chemometec.com

Pros

High customer switching costs for integrated lab equipment

Recurring revenue stream from proprietary consumables

Specialized market niche with high entry barriers

Proprietary technology protected by intellectual property

Demand driven by stringent industry regulatory requirements

Cons

Sensitivity to cyclical R&D spending in biotech

Risk of technological disruption from new analytical methods

Potential customer concentration in key industry segments

Competition from diversified life science tool providers

Dependency on external suppliers for critical instrument components

Company	AI Score	Compare
TECN.SWTecan Group AG
PRM.LProteome Sciences PLC
IKM.MC
ALNOV.PANovacyt SA
ALERS.PAEurobio Scientific SA

	Company	AI Score	Compare
1	PANG.MCPangaea Oncology SA
2	SFZN.SWSiegfried Holding AG
3	DXRX.LDiaceutics PLC
4	DIM.PASartorius Stedim Biotech SA
5	ERF.PAEurofins Scientific SE
6	BANB.SWBachem Holding AG
7	MLC.IRMalin Corporation PLC
8	CHEMM.COChemometec A/S
9	GUBRA.COGubra A/S
10	HEN.WA

	Company	AI Score	Compare
1	PANG.MCPangaea Oncology SA
2	SFZN.SWSiegfried Holding AG
3	DXRX.LDiaceutics PLC
4	DIM.PASartorius Stedim Biotech SA
5	ERF.PAEurofins Scientific SE
6	BANB.SWBachem Holding AG
7	MLC.IRMalin Corporation PLC
8	CHEMM.COChemometec A/S
9	GUBRA.COGubra A/S
10	HEN.WA

Company	AI Score	Compare
TECN.SWTecan Group AG
PRM.LProteome Sciences PLC
IKM.MC
ALNOV.PANovacyt SA
ALERS.PAEurobio Scientific SA

CHEMM.CO Stock AI Analysis

Chemometec A/S

CHEMM.CO Stock AI Analysis

Chemometec A/S

CHEMM.CO AI-Powered Stock Analysis

AI Score Explanation

AI Score Explanation

Generating AI Score explanation

AI Score Alpha Factors

Alpha Signals: What Drives the AI Score

CHEMM.CO probability advantage of beating the market (3M): -3.44%

CHEMM.CO Trading Parameters

CHEMM.CO Proven Hold Signal & Price Forecast

CHEMM.CO Average Past Performance & Win Rate

CHEMM.CO Frequently Asked Questions

Will Chemometec A/S stock go up?

Is it a good time to buy, sell, or hold Chemometec A/S stock right now?

What is going on with Chemometec A/S stock in the last 3 months?

Does Chemometec A/S offer dividend payments?

What is the current market capitalization of Chemometec A/S?

Chemometec A/S Company Profile

Pros

Cons

Pros

Cons

CHEMM.CO Company Profile Summary

CHEMM.CO Related Stocks

CHEMM.CO Top 10 Industry Stocks

Life Sciences Tools & Services

CHEMM.CO Top 10 Sector Stocks

Health Care

CHEMM.CO Stock AI Analysis

Chemometec A/S

OMX NORDIC EXCHANGE COPENHAGEN A/S

Will Chemometec A/S stock go up?

Is it a good time to buy, sell, or hold Chemometec A/S stock right now?

What is going on with Chemometec A/S stock in the last 3 months?

Does Chemometec A/S offer dividend payments?

What is the current market capitalization of Chemometec A/S?

OMX NORDIC EXCHANGE COPENHAGEN A/S

Pros

Cons

AI Score Explanation

CHEMM.CO Proven Hold Signal & Price Forecast